trans-Urocanic Acid

Research use only, not for human use.

trans-Urocanic Acid ((E)-Urocanic acid), a compound predominantly distributed in the hippocampus and prefrontal cortex, is an isomer of cis-UCA, an epidermal UV-protectant, which enhances the stability of tenofovir eplerenomide in long-acting HIV applications.

trans-urocanic acid (trans-UCA), a natural epidermal constituent, inhibits human natural killer cell (NK) activity in vitro. trans-urocanic acid is active in regulating an immune function.

trans-urocanic acid (trans-UCA) partially inhibits cytotoxic function of IL-2-activated NK cells and reduces IL-2-induced activation of NK cells. trans-urocanic acid (trans-UCA;100 μg/mL) slightly decreases cell proliferation and viability of primary human keratinocytes.Cell Proliferation Assay Cell Line:Primary human keratinocytes Concentration:100 μg/mL Incubation Time:24 hours Result:Decreased cell proliferation and viability.

——

——

Others

Other Targets

Others

——

——

3465-72-3

138.12

C6H6N2O2

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (724.01 mM; Ultrasonic )

C(=C/C(O)=O)\C1=CN=CN1

——

(-20℃)

With Ice Pack

≥ 2 years